Anticarcinogenic Effect of Spices Due to Phenolic and Flavonoid Compounds-In Vitro Evaluation on Prostate Cells

Zuzana Lackova1,2, Hana Buchtelova3,4, Zaneta Buchtova5

  • 1Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, Brno CZ-613 00, Czech Republic. lackova14@seznam.cz.

Insights

Black pepper and caraway seed extracts show potent effects on prostate cells. Naringenin chalcone from black pepper was identified as the most effective inhibitor of prostate cell growth.

Area of Science:

  • Phytochemistry
  • Cell Biology
  • Oncology

Background:

  • Prostate cancer is a significant health concern.
  • Natural compounds from spices offer potential therapeutic avenues.
  • Understanding the effects of specific phytochemicals on prostate cells is crucial.

Purpose of the Study:

  • To investigate the impact of spice extracts and their compounds on prostate cell lines.
  • To identify specific phenolic and flavonoid compounds responsible for inhibitory effects.
  • To determine the most potent natural inhibitor of prostate cell growth.

Main Methods:

  • MTT assay to evaluate cytotoxicity of spice extracts and compounds.
  • Liquid Chromatography-Mass Spectrometry (LC/MS) for compound identification.
  • Scratch assay to assess cell migration inhibition.

Main Results:

  • Black pepper and caraway seed extracts exhibited the strongest inhibitory effects on prostate cells (PNT1A, 22RV1, PC3) at 12.5 mg·mL-1.
  • LC/MS identified key compounds: 3,4-dihydroxybenzaldehyde and naringenin chalcone in black pepper; neochlorogenic acid and apigenin in caraway seeds.
  • Naringenin chalcone demonstrated the most potent inhibition of prostate cell growth, with an IC50 of ~1 mmol·L-1 on PNT1A cells.

Conclusions:

  • Spice-derived compounds, particularly naringenin chalcone from black pepper, possess significant potential for inhibiting prostate cell proliferation.
  • Naringenin chalcone is identified as a highly effective natural inhibitor of prostate cell growth.
  • Further research into naringenin chalcone as a therapeutic agent for prostate conditions is warranted.